These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 7031536)
1. Adverse effects of cardiovascular drug therapy on the fetus and neonate. Witter FR; King TM; Blake DA Obstet Gynecol; 1981 Nov; 58(5 Suppl):100S-5S. PubMed ID: 7031536 [TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular drugs and pregnancy]. Lion MF; de Andrade J Arq Bras Cardiol; 1981 Aug; 37(2):125-7. PubMed ID: 7348176 [No Abstract] [Full Text] [Related]
3. Special considerations in the use of cardiovascular drugs. Ueland K; McAnulty JH; Ueland FR; Metcalfe J Clin Obstet Gynecol; 1981 Sep; 24(3):809-23. PubMed ID: 7026105 [No Abstract] [Full Text] [Related]
5. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Qasqas SA; McPherson C; Frishman WH; Elkayam U Cardiol Rev; 2004; 12(4):201-21. PubMed ID: 15191632 [TBL] [Abstract][Full Text] [Related]
6. [Pregnancy and cardiac drugs]. Grand A Rev Fr Gynecol Obstet; 1993 May; 88(5):297-312. PubMed ID: 8327817 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of arrhythmia during pregnancy]. Runge M Dtsch Med Wochenschr; 1984 Jun; 109(24):959-64. PubMed ID: 6145573 [No Abstract] [Full Text] [Related]
8. The effects of chronic gastrointestinal medication on the fetus and neonate. Witter FR; King TM; Blake DA Obstet Gynecol; 1981 Nov; 58(5 Suppl):79S-84S. PubMed ID: 7031544 [TBL] [Abstract][Full Text] [Related]
9. Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications. Newstead-Angel J; Gibson PS Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1569-80. PubMed ID: 19954319 [TBL] [Abstract][Full Text] [Related]
10. [Pregnancy and cardiovascular agents]. Grand A Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):549-64. PubMed ID: 1300918 [TBL] [Abstract][Full Text] [Related]
11. [Fetal risks related to the administration of anti-arrhythmia drugs during pregnancy]. Ferrero S; Colombo BM; Arena E; Fenini F; Ragni N Ital Heart J Suppl; 2002 Oct; 3(10):993-1002. PubMed ID: 12478825 [TBL] [Abstract][Full Text] [Related]
12. [Anticoagulants and fibrinolytics in pregnancy]. Walther C Zentralbl Gynakol; 1976; 98(8):465-7. PubMed ID: 961203 [TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive drugs during pregnancy. Effects on the fetus]. D'Anna R; Mancuso A; Sciarrone A; Palmara V; Barbaro L; Leonardi R Minerva Ginecol; 1992 Mar; 44(3):67-77. PubMed ID: 1565284 [TBL] [Abstract][Full Text] [Related]
15. [Use of cardiovascular drugs in pregnancy]. Halawa B Wiad Lek; 1989 Jan; 42(2):94-100. PubMed ID: 2683387 [No Abstract] [Full Text] [Related]
16. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Vink GJ; Moodley J; Philpott RH Obstet Gynecol; 1980 Apr; 55(4):519-22. PubMed ID: 7366909 [TBL] [Abstract][Full Text] [Related]
17. [Use of cardiovascular agents in women during pregnancy]. Halawa B Kardiol Pol; 1993 Apr; 38(4):283-7. PubMed ID: 8105134 [No Abstract] [Full Text] [Related]
18. Drug risks in pregnancy revisited. Guillozet N J Fam Pract; 1977 Jun; 4(6):1043-52. PubMed ID: 69010 [TBL] [Abstract][Full Text] [Related]
19. [Drugs, hormones and inoculations during pregnancy]. Moayer M Munch Med Wochenschr; 1972 Apr; 114(16):748-54. PubMed ID: 4556637 [No Abstract] [Full Text] [Related]
20. [Skin side effects of preparations with cardiovascular action]. Romanenko GF; Mozherenkov VP Vestn Dermatol Venerol; 1984 Feb; (2):25-8. PubMed ID: 6232772 [No Abstract] [Full Text] [Related] [Next] [New Search]